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Abstract 
As substance use increases in the United States, the number of neonates born with 
neonatal abstinence syndrome (NAS) has also increased from women using substances during 
pregnancy.  Consequently, the healthcare industry has noticed a significant rise in the number of 
neonates born with NAS withdrawal symptoms, increasing healthcare costs and need for 
evidence-based practice.  The purpose of this systematic review is to appraise the evidence 
regarding the effects of supplemental nonpharmacological interventions, specifically 
breastfeeding and rooming-in, compared to standard pharmacological treatment, on outcomes in 
neonates with NAS.  Twenty peer-reviewed research studies conducted between 2010 and 2018 
were obtained from scholarly databases. Studies were analyzed based on relevance to neonates 
experiencing NAS symptoms and nonpharmacological interventions of breastfeeding and 
rooming-in.  Researchers consistently concluded that breastfeeding and rooming-in positively 
impact NAS outcomes by decreasing the need for pharmacological treatment, severity of NAS 
withdrawal symptoms, and length of stay.   
Keywords: neonatal abstinence syndrome, opioids, pharmacological treatment, 
nonpharmacological interventions, length of stay, LOS, neonatal outcomes, breastfeeding, 
rooming-in 
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Effects of Nonpharmacological Interventions on Outcomes in Neonates with Neonatal 
Abstinence Syndrome: A Systematic Review 
The United States is falling deeper into the midst of an intensifying opioid epidemic as 
evidenced by 42,000 deaths from opioid overdoses in 2016, which is five times the number of 
deaths in 1999 (Centers for Disease Control and Prevention [CDC], 2018). Women of 
childbearing age constitute a large portion of those suffering from opioid use. In fact, nearly one-
third of those people being treated for opioid addiction are women of the childbearing age 
(O’Connor, Collett, Alto, & O’Brien, 2013).  This is a significant problem because 21,732 
neonates in 2012 were born with opiate withdrawal symptoms; therefore, an addicted neonate is 
born every 25 minutes (National Institute on Drug Abuse, 2015). 
Substance abuse during pregnancy leads to the development of neonatal abstinence 
syndrome (NAS) in neonates.  NAS is classified as the possible withdrawal syndrome that 
neonates may experience due to in-utero exposure to opioids and is “characterized by 
hyperirritability of the central nervous, the gastrointestinal, the respiratory and the autonomic 
nervous systems” (Welle-Strand et al., 2013, p. 1060).  Various consequences affecting addicted 
mothers and neonates include but are not limited to: intrauterine growth restriction, preterm 
rupture of membranes, placental insufficiency, premature birth, postpartum hemorrhage, and 
potentially perinatal mortality (O’Connor et al., 2013).  These perinatal and postpartum 
complications lead to high-risk pregnancies and postpartum periods, causing detrimental effects 
on neonates and mothers.  Neonates at risk for NAS are carefully monitored for signs and 
symptoms of withdrawal.  The effects of NAS in the immediate postpartum period include 
increased chance of disrupted mother-neonate bonding, sleeping and feeding difficulties, weight 
loss, and seizures (Bhatt-Mehta, Ng, & Schumacher, 2014).  These problems often make the 
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neonatal transition difficult and may result in admission to neonatal intensive care units (NICU) 
(McKnight et al., 2016).   
Moreover, the rise in neonates with NAS has consequences for the healthcare industry, 
increasing length of hospital stays and costs.  With increased NAS incidence and treatment, the 
costs of care per neonate rose 30% to approximately $69,000, from 2009 to 2012, resulting in 
$1.5 billion in additional hospital charges overall (Crook & Brandon, 2017).  Furthermore, as 
many as 50% of neonates with NAS are sent to NICUs, consequently diminishing available beds 
for neonates experiencing other indispositions (Loudin et al., 2017).  Newborns with NAS 
symptoms are often treated in NICUs to ensure neonatal well-being and symptom management 
(Holmes et al., 2016).  When neonates are admitted to NICUs, costs per case can be as high as 
$93,000 compared to $20,000 for standard neonatal care (Howard et al., 2017).  Additionally, 
less costly nonpharmacological interventions are difficult to implement when neonates are 
treated in NICUs due to the mother-neonate separation. 
Within the first postnatal days, neonates exposed to opioids in utero begin to express 
withdrawal symptoms; thus, further action is needed to avoid major complications (Hünseler, 
Brückle, Roth, & Kribs, 2013).  Withdrawal symptoms in neonates are quantified using the 
Finnegan scale, which is a systematic method of scoring 21 signs that grade neonatal withdrawal 
severity (Timpson, Killoran, Maranda, Picarillo, & Bloch-Salisbury, 2018).  The Finnegan 
Scoring System measures central nervous system symptoms, such as high-pitched crying, ease of 
feeding, muscle tone, and temperature (McQueen, Murphy-Oikonen, Gerlach, & Montelpare, 
2011).  Nurses subjectively rate each sign with a numerical value from one to three, based on the 
severity of the symptoms, and these values are added together for a total score.  Three 
consecutive scores greater than or equal to eight are indicative of NAS (O’Connor et al., 2013).    
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Regarding the need for pharmacological treatment to relieve NAS symptoms, over half of 
neonates exposed to opioids need such pharmacological intervention (Howard et al., 2017).  The 
first-line treatment for neonates expressing symptoms of NAS includes opiates, such as 
methadone and buprenorphine (Hünseler et al., 2013).  Methadone therapy is begun if neonates 
score higher than eight on two consecutive occasions when using the Finnegan scale (Isemann, 
Meinzen-Derr, & Akinbi, 2011).  The pharmacological treatment of NAS with methadone may 
cause hypertonicity, irritability, and disorganized sucking, further complicating neonates’ 
withdrawal symptoms and breastfeeding (Demirci, Bogen, & Klionsky, 2015).  If neonates reach 
maximum dosage of methadone and continue displaying signs of NAS withdrawal, phenobarbital 
can be used as a second-line therapy (Howard et al., 2017).  Eventually, pharmacological 
treatment is weaned to the lowest dose and discontinued.  Before neonates are discharged home, 
they are monitored for 24 to 48 hours following completion of opioid replacement therapy 
(Howard et al., 2017).  Consequently, the use of pharmacologic therapy increases the length of 
stay (LOS) in neonates with NAS. 
Nurses may supplement treatment with nonpharmacological interventions, such as 
breastfeeding and rooming-in, which have been found to promote bonding and attachment in 
neonates and to decrease the severity of withdrawal symptoms (Newman et al., 2015; Pritham, 
Paul, & Hayes, 2012).  Benefits of these nurse-driven interventions include decreased costs and 
fewer side effects.  The purpose of this systematic review is to identify and critically appraise the 
evidence regarding effects of supplemental nonpharmacological interventions, specifically 
breastfeeding and rooming-in, compared to standard pharmacological treatment, on outcomes in 
neonates with NAS withdrawal symptoms.  This systematic review will answer the following 
PICOT question: In neonates exposed to opioids in utero, how do supplemental 
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nonpharmacological interventions, compared to standard pharmacological treatment alone, affect 
neonatal outcomes directly after birth through discharge from the hospital?  This systematic 
review is significant to nurses because, with an increased number of pregnant women abusing 
opioids, nurses have seen a fivefold increase in neonates expressing signs and symptoms of NAS 
within the past 15 years (Schiff et al., 2018).  Since pharmacotherapy is associated with side 
effects and complications, nurses need to promote positive outcomes for neonates with NAS by 
enhancing practice. This should be based on evidence regarding the effectiveness of nurse-
initiated, nonpharmacological interventions.  
Methods 
The goal of the search was to identify studies that met inclusion criteria, specifically 
where nonpharmacological treatment was provided and compared to standard care of neonates 
with NAS.  Common nonpharmacological interventions identified by the search were 
breastfeeding and rooming-in, which consequently promote bonding and attachment in the early 
phase of the NAS-affected neonates’ lives (Newman et al., 2015; Pritham et al., 2012).  The 
desired time period of outcomes was from the birth of the neonates to discharge from the 
hospital.  The studies were published between 2010 and 2018 and were found in the following 
databases: CINAHL Plus with Full Text, MEDLINEPlus, PSYCHInfo, and SOCIndex. 
After identifying pertinent nonpharmacological interventions, keywords included 
neonatal abstinence syndrome, NAS, withdrawal, breastfeeding, rooming-in, and opioid 
treatment.  A search with keywords of ‘neonatal abstinence syndrome or NAS or withdrawal’ 
and ‘breastfeeding or rooming-in’ resulted in 499 articles.  ‘Neonatal abstinence syndrome’ and 
‘breastfeeding’ and ‘opioid treatment’ yielded 20 publications.  ‘NAS or neonatal abstinence 
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syndrome’ and ‘breastfeeding’ produced 5,002 publications.  In addition, ‘NAS or neonatal 
abstinence syndrome’ and ‘rooming-in’ produced 7,109 publications.  
Additionally, the US National Library of Medicine’s PubMed Central (PMC) database 
was searched.  Keywords of ‘neonatal abstinence syndrome’ and ‘breastfeeding’ and ‘opioid 
maintenance treatment’ produced 83 results.  Lastly, Google Scholar databases were searched 
with keywords of ‘rooming-in’ and ‘neonatal abstinence syndrome’, yielding 856 results, and 
with ‘neonatal abstinence syndrome’ and ‘breastfeeding’ and ‘rooming-in’, resulting in 624 
results.  
At the beginning of the searching procedure, publications that were older than five years 
were excluded using advanced search methods within the databases.  Since retrieved publications 
were limited in number within this time frame, criteria were extended to eight years.  This 
allowed for identification of more publications relevant to and answering the PICOT 
question.  Exclusion criteria included secondary sources, literature reviews, or meta-analyses; 
therefore, only primary sources were included in the review.  Publications were selected without 
bias to show variation and inconsistencies that were present in findings.   
Throughout the searches, many publications were carefully reviewed to determine if they 
answered the PICOT question and discussed the impact of breastfeeding and rooming-in 
compared with standard care of neonates with NAS.  This was done by first analyzing the title of 
each article and then, if applied to the research question, content was read for relevancy.  After a 
comprehensive review of all major relevant research, a total of 20 studies were included in this 
systematic review.  
Review of Literature 
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The 20 studies obtained for this systematic review were carefully read to determine their 
relevance to NAS symptoms and nonpharmacological interventions of breastfeeding and 
rooming-in.  The setting of the studies ranged from locations as close as Cincinnati, Ohio to as 
far as Western Sydney and Norway.  The most commonly used design was a comparison cohort, 
generating level four evidence.  In all but one study, researchers reviewed the medical records of 
mothers and neonates who met inclusion and exclusion criteria and compared neonates who 
received standard care to those who roomed-in with their mothers or were breastfed.  In the study 
that was the exception, researchers collected data with questionnaires from mothers who were 
invited to participate in the study.  Because many of these studies were performed by examining 
medical records, prior documentation may not have been an accurate representation of the care 
that was provided.  Unlike consistent sampling and data collection methods across studies, 
sample sizes varied greatly from only 11 up to 3,725 participants.  This may limit researchers’ 
findings since small sample sizes are not as representative of the entire population.  In the 
following sections, breastfeeding interventions and outcomes in neonates with NAS will be 
initially presented, followed by rooming-in interventions and outcomes in this 
population.  Intervention outcomes include pharmacological use, NAS symptoms and scores, and 
LOS.  
Breastfeeding  
One major nonpharmacological intervention used to affect outcomes in neonates with 
NAS is breastfeeding.  Newborns’ optimal nutrition is maternal milk, and in general, 
breastfeeding has positive impact on both the mothers’ and neonates’ health, as well as early 
bonding and attachment (Welle-Strand et al., 2013).  Additionally, the severity of NAS 
symptoms are mitigated as maternal opioids are transferred in the breast milk (Demirci et al., 
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2015).  The women included in these studies met certain requirements in order to breastfeed their 
neonates (Schiff et al., 2018).  For example, contraindications to breastfeeding included illicit 
drug use, HIV, herpes lesions on the breasts, hepatitis C with nipples that are cracked and 
bleeding, or other prescription medications that are transmitted through the breastmilk and 
harmful to the neonates (Short, Gannon, & Abatemarco, 2016).  
Across the 20 studies, researchers specified findings related to breastfeeding and how it 
can affect neonates exhibiting NAS.  For example, researchers in six studies found that 
breastfeeding can decrease the need for pharmacological treatment (Grossman et al., 2017; 
Hodgson & Abrahams, 2012; Liu, Juarez, Nair, & Nanan, 2015; O’Connor et al., 2013; Welle-
Strand et al., 2013; Yonke, Maston, Weitzen, & Leeman, 2018).  Researchers in five studies also 
found that breastfeeding reduced NAS scores and symptoms of neonates (Demirci et al., 2015; 
Liu et al., 2015; McQueen et al., 2011; O’Connor et al., 2013; Welle-Strand et al., 2013).  Lastly, 
researchers of seven studies supported that breastfeeding can lead to a decreased average length 
of stay in neonates with NAS (Crook & Brandon, 2017; Grossman et al., 2017; Isemann et al., 
2011; Pritham et al., 2012; Schiff et al., 2018; Short et al., 2016; Well-Strand et al., 2013).   
Pharmacological therapy.  Several researchers have found that breastfeeding diminishes 
the need for pharmacological therapy with reductions ranging from 84% to 6.9% (Grossman et 
al., 2017;Hodgson & Abrahams, 2012; Liu et al., 2015; O’Connor et al., 2013; Welle-Strand et 
al., 2013; Yonke et al., 2018).  In the study conducted by Yonke et al. (2018) of 228 neonates, 
the percentage of neonates that were breastfed and required pharmacological intervention 
decreased by 31.6% compared to the formula fed group.  Similarly, in a study of 194 mother-
neonate dyads, Liu et al. (2015) found that by adhering mostly to breastfeeding during the early 
postpartum period, NAS pharmacological treatment decreased by 37%.  However, Welle-Strand 
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et al. (2013) studied 124 neonates and concluded that only a 12% decreased need for 
pharmacological treatment was associated with breastfed neonates versus non-breastfed 
neonates.  Additionally, O’Connor et al. (2013) studied 85 maternal-neonate pairs and found a 
6.9% decreased need for pharmacotherapy.  
NAS scores and symptoms.  Researchers have consistently found that breastfeeding 
delays the onset of NAS symptoms, lessens severity of symptoms, and overall decreases mean 
NAS scores (Demirci et al., 2015; Liu et al., 2015; McQueen et al., 2011; O’Connor et al., 2013; 
Welle-Strand et al., 2013).  Several researchers examined the effects of breastfeeding in relation 
to NAS scores.  McQueen et al. (2011) used a modified Finnegan Scoring System and found that 
breastfeeding reduced the Finnegan mean score in 28 neonates; the mean peak score of the 
breastfed group was 4.9 versus formula-fed of 6.9.  On the other hand, O’Connor et al. (2013) 
discovered that of 85 neonates, the breastfed group in their study had a mean Finnegan peak 
score of 8.83 versus 9.65 in the formula-fed group.  Both research groups found that a score of 
eight or above was less likely to occur in those neonates who were breastfed; thus, 
pharmacological treatment with buprenorphine or methadone was not required (McQueen et al., 
2011; O’Connor et al., 2013).  McQueen et al. (2011) found that 40.2% of formula-fed neonates 
scored higher than eight on the Finnegan scale requiring pharmacological therapy, compared to 
only 17% of breastfed neonates.  NAS withdrawal scoring is subjective, which suggests that 
Finnegan totals will vary based on the healthcare professional performing the assessment.  This 
identifies a limitation that must be considered when analyzing the relationships between NAS 
scores and nonpharmacological intervention implementation. 
Length of stay.  Hospital LOS is another outcome of breastfeeding in neonates with 
NAS (Crook & Brandon, 2017; Grossman et al., 2017; Isemann et al., 2011; Pritham et al., 2012; 
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Schiff et al., 2018; Short et al., 2016; Welle-Strand et al., 2013).  Differences in LOS for 
breastfed neonates with NAS and those not breastfed ranged from 16.5 days to 2.78 days.  In a 
study of 287 neonates, Grossman et al. (2017) discovered that the average LOS decreased from 
22.4 to 5.9 days when breastfeeding was implemented, which was a 74% reduction.  
Additionally, the average LOS of 200 neonates who were only pharmacologically treated was 
12.74 days longer than those who were breastfed (Crook & Brandon, 2017).  However, in 
contrast, Isemann et al. (2011) and Schiff et al. (2018) both discovered a three-day decrease in 
LOS with sample sizes of 128 and 564 respectively, when breastfeeding was implemented.  
Crook & Brandon (2017) also found that neonates solely breastfed had a 2.78-day shorter LOS 
compared to those who received more than 50% human milk during hospitalization.   
In the process of compiling research, hospital readmission was identified as a gap in 
knowledge.  Neonates were analyzed until hospital discharge; consequently, information on 
whether or not neonates were readmitted to the hospital for further treatment was not available. 
This is due to the collection method utilized in the studies, which limited data to the initial 
hospital stay.  
Rooming-In  
Another method shown to improve outcomes in neonates with NAS is rooming-in, which 
prevents separation of mothers and neonates during the critical time after birth and promotes 
effective bonding and attachment (Newman et al., 2015).  Howard et al. (2017) described 
rooming-in as allowing neonates to stay in the same room as their mothers during 
hospitalization.  Neonates who room-in require less pharmacological therapy, experience less 
severe signs of NAS, and have decreased hospital LOS (Newman et al., 2015).  In general, 
researchers have concluded that rooming-in positively affects neonates with NAS.  
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Of the 20 studies in this systematic review, a majority discussed the impact of rooming-in 
on neonates experiencing NAS symptoms.  Researchers in seven studies clarified outcomes of 
rooming-in with the need for pharmacological treatment (Hodgson & Abrahams, 2012; Holmes 
et al., 2016; Howard et al., 2017; Hünseler et al., 2013; McKnight et al., 2016; Newman et al., 
2015; Saiki, Lee, Hannam, & Greenough, 2010).  Researchers of two studies described the 
effects of rooming-in on the severity of NAS scores and symptoms (Howard et al., 2017; 
Hodgson & Abrahams, 2012).  Researchers of eight studies also examined the effects of 
rooming-in implementation on related hospital LOS (Abrahams et al., 2010; Grossman et al., 
2017; Holmes et al., 2016; Howard et al., 2017; Hünseler et al., 2013; McKnight et al., 2016; 
Newman et al., 2015; Saiki et al., 2010).   
Pharmacological therapy.  Researchers have consistently reported that rooming-in 
decreases the need for pharmacological treatment with methadone and buprenorphine (Holmes et 
al., 2016; Howard et al., 2017; Hünsler et al., 2013; McKnight et al., 2016; Newman et al., 2015; 
Saiki et al., 2010).  The percentage of neonates requiring pharmacological treatment decreased, 
ranging from 9% to 69% when rooming-in was implemented (Holmes et al., 2016; Hünsler et al., 
2013; McKnight et al., 2016; Newman et al., 2015; Saiki et al., 2010).  Hünsler et al. (2013) and 
Howard et al. (2017) found that rooming-in and maternal involvement reduced the need for 
pharmacological therapy by 17% and 19% respectively, with sample sizes of 77 and 86 
neonates.  Additionally, researchers have examined other factors related to rooming-in that may 
contribute to reduced need for pharmacotherapy.  For example, Hünseler et al. (2013) found that 
the increased mother-baby contact associated with rooming-in, such as cuddling and swaddling, 
contributed to decreased need for pharmacological intervention.  Also, because the postpartum 
units are typically quieter than the neonatal units, the difference in environments could also 
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influence the reduced need for pharmacotherapy (Saiki et al., 2010).  The effectiveness of 
rooming-in on pharmacological therapy may not be as accurate because, as stated above, other 
factors such as swaddling and skin-to-skin contact occur simultaneously.  
NAS scores and symptoms.  Rooming-in has decreased Finnegan peak NAS scores and 
has also been observed to decrease the severity of withdrawal symptoms in neonates suffering 
with NAS symptoms (Hodgson & Abrahams, 2012; Howard et al., 2017).  In a sample of 86 
neonates, Howard et al. (2017) reported that average Finnegan NAS scores of roomed-in 
neonates with increased maternal presence were significantly lower compared with those not 
roomed-in, and the average NAS score was decreased by one point on the Finnegan scale 
following 100% maternal presence.  Similarly, according to Hodgson & Abrahams (2012), 295 
neonates who were allowed to room-in with their mothers had a decreased rate of developing 
NAS symptoms, and if the symptoms did develop, the need for treatment was reduced compared 
to their non-breastfed counterparts.  
Length of stay.  Length of hospital stay in neonates with NAS is crucial, as extended 
NICU stays are detrimental to early bonding efforts and family interactions (Abrahams et al., 
2010).  Many researchers explored the effects of rooming-in on neonatal LOS and found 
reductions ranging from 3.9 to 19 days (Grossman et al., 2017; Holmes et al., 2016; Howard et 
al., 2017; Hünseler et al., 2013; McKnight et al., 2016; Newman et al., 2015; Saiki et al., 2010).   
In a study conducted by Newman et al. (2015) to identify the effects of rooming-in on a sample 
of 21 neonates, the LOS decreased from approximately 25 to 8 days when rooming-in was 
implemented.  Furthermore, reductions from 16.9 to 12.3 days were reported by Holmes et al. 
(2016) in a study of 163 neonates.  Additionally, a nine-day decrease in average LOS was noted 
by Howard et al. (2017) when rooming-in was completed.  These researchers discovered reduced 
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LOS from rooming-in; however, Abrahams et al. (2010) found a ten-day increase in LOS from 
NICU standard care to rooming-in.  In this study, both neonates and mothers had longer stays; 
the rooming-in LOS was 21 days and the standard care was 11 days.  Based on findings in other 
studies, it is unknown what factors caused this increased LOS.  
Critical Appraisal of the Evidence 
Limitations of Findings 
Throughout this systematic review of the literature, breastfeeding and rooming-in were 
analyzed to determine the effects on neonatal outcomes.  Limitations include the Finnegan 
Scoring System of NAS symptoms, pharmacological need with rooming-in, polysubstance abuse 
and underreporting of maternal drug use, and factors influencing LOS.  
First, a major limitation is the method by which the neonates’ symptoms are scored.  
Some facilities implemented the Finnegan Scoring System while others used a modified system 
focusing on fewer neonatal outcomes.  However, even if the same Finnegan scale was used 
across studies, the results would still be inconsistent because of the system’s subjectivity.  For 
example, if a neonate is experiencing tremors, one nurse may think that they are mild and rate 
them accordingly; however, another nurse could think they were quite significant, rating them 
much differently.  
 Another limitation of findings is related to the effects of rooming-in on the need for 
pharmacological therapy.  Rooming-in is difficult to be measured independently because other 
factors are involved when rooming-in takes place.  For instance, if the neonate is in the same 
room as the mother, higher incidences of swaddling and skin-to-skin contact will most likely 
occur compared to neonates who reside in the nursery.  Therefore, it is hard to determine whether 
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the actual rooming-in was beneficial, or if mother-neonate contact was correlated to differences 
in pharmacological needs. 
 Maternal drug use is unclear due to the large variability as well as self-reporting of drug 
use by the mothers included in the studies.  Many studies concluded that drug use during 
pregnancy was often underreported and some mothers used multiple drugs simultaneously, 
ultimately leading to inaccurate data and different symptom presentation in neonates after birth 
(Bhatt-Mehta et al., 2014; Liu et al., 2015; McKnight et al., 2016; O’Connor et al., 2013; Pritham 
et al., 2012).  
 Additionally, it was not possible to accurately determine factors influencing neonatal 
LOS.  In some of the studies, rooming-in and breastfeeding decreased the LOS (Grossman et al., 
2017; Holmes et al., 2016; Howard et al., 2017; Hünseler et al., 2013; McKnight et al., 2016; 
Newman et al., 2015; Saiki et al., 2010); however, in one study, the LOS was considerably 
greater in the rooming-in group compared to those who received standard care (Abrahams et al., 
2010).  As a result, other factors may have influenced this change that were not specified in the 
studies. Plus, due to the data collection method focusing only on neonates’ initial hospital stay, 
data on readmission for further treatment was limited.  
Validity and Reliability of Methods 
In the studies for this systematic review, validity and reliability varied.  Nearly all the 
studies were retrospective, which posed questions regarding the validity of the reports; 
retrospective studies rely on past information that was documented, which could be interpreted 
incorrectly.  Additionally, retrospective studies lack randomization since inclusion criteria is 
determined by the researchers.   
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Reliability is another issue that must be considered to determine whether the findings are 
accurate.  In many of the studies, maternal drug use was self-reported, which could have led to 
underreporting and data alteration.  Furthermore, studies with larger sample sizes are more 
reliable, decreasing the margin of error and increasing generalizability (Demirici et al., 2015).  
Another factor contributing to decreased reliability is the NAS symptom scoring tools which 
were different across the studies.  Several studies used the Finnegan Scoring System (Grossman 
et al., 2017; Howard et al., 2017; Hunseler et al., 2013; Isemann et al., 2011; Liu et al., 2015; 
Newman et al., 2015; O’Connor et al., 2013) where others used a modified Finnegan Scoring 
System (Holmes et al., 2016; McKnight et al., 2016; McQueen et al., 2011) or other methods 
(Demirci et al., 2015; Short et., 2016; Welle-Strand et al., 2013).  
Limitations Across Studies 
Across studies, there were limitations identified that may have impacted the study 
processes.  An important limitation is small sample sizes, which can prevent accurate results.  
Throughout the process of identifying articles for the systematic review, there was a limited 
number of available studies published within five years.  Therefore, search criteria were 
extended to eight years to allow for identification of additional research. 
Maternal situations should also be analyzed as the methods of study may have prevented 
certain outcomes and interventions.  If a randomized method was used, mothers would have been 
told whether or not to breastfeed, which would be unethical.  Additionally, some of the mothers 
were not able to breastfeed due to illicit drug use, HIV, herpes lesions on the breasts, hepatitis C 
with nipples that are cracked and bleeding, or other prescription medications (Short et al., 2016).  
Lastly, some studies did not list whether the mothers had used methadone, buprenorphine, or 
another medication-assisted treatment, which could have altered results.   
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Synthesis of the Evidence 
 From this systematic review, evidence was critically appraised to determine the current 
state of science.  The results of the literature review all pointed to the positive effects of 
rooming-in and breastfeeding, except for one article (Abrahams et al., 2010).  Due to the 
consistency of the findings, these studies are an accurate representation of current interventions 
that can be used to promote positive effects in neonates with NAS.  
Recommendations 
After an extensive review of research, potential practice and research implications for 
future studies were determined.  Many of these studies proved that breastfeeding and rooming-in 
methods of nonpharmacological treatment have been efficient in reducing the need for 
pharmacological treatment, decreasing the overall length of stay, and minimizing the NAS signs 
and symptoms displayed by neonates.  Therefore, breastfeeding and rooming-in should be 
recommended and encouraged by all healthcare professionals.  
 First, it is recommended that a standard screening process should be developed for 
neonates who are at risk of developing NAS and mothers who have a history of substance abuse.  
In addition to this screening process, mothers should be encouraged to take part in an educational 
program to teach them the benefits of prenatal preventative measures rather than reactive 
measures requiring symptom management after birth.  These mothers should also be educated on 
the benefits of nonpharmacological measures such as breastfeeding and rooming-in and the 
positive impact they have on neonatal outcomes.  Extra support and education may be needed for 
these high-risk mothers that encounter stigmatization due to their substance abuse.  From this, it 
is important that medical treatment, resources, and classroom teaching should be made readily 
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available throughout the community or in local hospitals to increase the incidence of mothers 
who stop or decrease the abuse of illicit substances.  
Another recommendation is to create an atmosphere within the hospital that encourages 
rooming-in for neonates showing signs of withdrawal.  Nurses and doctors on the postpartum 
floors should be given special education on caring for neonates who are experiencing NAS 
withdrawal symptoms so they can provide appropriate care.  Furthermore, implementation of a 
standardized scoring method, such as a modified or improved Finnegan system, should be 
considered to determine when symptoms are too severe that neonates can no longer be treated on 
a normal postpartum floor.  This may help to alleviate overcrowded NICUs, especially as 
neonates with NAS are becoming more prevalent with a rise in drug abuse.   
Future studies that could advance nursing practice in this area should be focused on 
identifying childbearing women’s preconceived beliefs about breastfeeding and addressing these 
fears and factors that inhibit its practice.  Future studies should be done to determine why women 
choose not to breastfeed and to identify specific factors that prevent them from continuing 
breastfeeding outside of the hospital setting.  Healthcare providers need to address these factors 
to increase breastfeeding in this at-risk population in order to decrease NAS withdrawal in  
neonates.  In addition, healthcare providers need to stress the importance and impact that 
breastfeeding can have on NAS withdrawal severity to mothers during prenatal visits.  Because it 
has been concluded that breastfeeding prevalence is higher in women who room-in with their 
neonates, future studies should include a statistical examination of the relationship between 
rooming-in and breastfeeding rates.  Additionally, at-risk mothers may also need extra support 
and guidance to help initiate the breastfeeding process; therefore, a lactation consultant may be 
EFFECTS OF NONPHARMACOLOGICAL INTERVENTIONS    19 
effective in assisting and educating the mother, as well as providing encouragement to continue 
breastfeeding.  
In regard to the research design, future studies should collect data prospectively rather 
than retrospectively.  Additionally, studies should have larger sample sizes to prove their 
reliability and to make larger conclusions about the populations being studied.  Regarding the 
signs and symptoms of NAS, studies should not solely focus on the neonatal period but should 
extend criteria in order to follow the child through the developmental process.  A longer study 
period would have benefits of identifying how NAS affects its subjects later in life related to 
growth and mental capabilities.   
Conclusion 
 Breastfeeding and rooming-in are beneficial for neonates who are experiencing 
symptoms of NAS.  From the studies analyzed in this systematic review, many positive 
outcomes were measured as a result of breastfeeding and rooming-in implementation such as 
decreased use of pharmacological therapy, NAS scores and symptoms, and LOS.  However, 
there are many additional factors that need to be identified and quantified in future studies as 
well as interventions and programs that can be implemented to decrease NAS prevalence in 
childbearing mothers who abuse substances.  
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Setting: Fir 
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need for 
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S. L. (2016). Rooming-in 
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Purpose Statement: The 
purpose was to see if 
the program, which 
included modified 
scoring scales and 
standardized 
pharmacological 
treatment, had an 
impact on family-
centered care and length 
of hospital stay.  
Research Question: 
Does implementation of 
adapted scoring tools 
and standardized 
pharmacological 
treatment increase the 
involvement of the 
family as well as 
decrease the length of 
stay in the neonate 
affected by NAS?  
Setting: 
Children’s 
Hospital at 
Dartmouth-
Hitchcock  
Sampling 
method: All 
patient charts 
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Sample size: 163 
Design: 
Comparison 
cohort study 
Level of 
Evidence: IV 
The standard 
pharmacological 
treatment of 
NAS symptoms 
decreased after 
project 
implementation 
as well as the 
average length of 
stay, and there 
were no adverse 
effects noted 
from this study.  
Standardizing 
scoring methods, 
promoting family 
involvement, such 
as rooming-in, and 
managing NAS both 
environmentally and 
pharmacologically 
is important to 
promoting 
decreased 
withdrawal 
symptoms in 
affected neonates.  
This study was held in a 
labor and delivery unit in 
a children’s hospital, 
which could impact the 
results and limit 
generalizability. Because 
this quality improvement 
was initiated with a small 
group of doctors and 
nurses, change was easy; 
however, this may be 
more difficult to 
implement in larger 
groups.  The mothers in 
this study were from a 
predominantly rural area 
and are ethnically 
homogeneous, and there 
also were a lot more 
mothers on 
buprenorphine than 
methadone, which can 
result in a shorter length 
of treatment.  
7. Howard, M. B., Schiff, 
D. M., Penwill, N., Si, W., 
Rai, A., Wolfgang, T., … 
Wachman, E. M. (2017). 
Impact of parental 
presence at infants’ 
bedside on neonatal 
abstinence syndrome. 
Hospital Pediatrics, 7(2), 
63–69. https://doi-
Purpose Statement: This 
study’s objective was to 
determine the 
association between 
parental presence 
(rooming-in) and 
involvement in care 
compared to NAS 
Setting: Boston 
Medical Center  
Sampling 
method: All 
patient charts 
that met criteria 
Design: 
Retrospective 
cohort study 
Level of 
evidence: IV  
Withdrawal 
severity, 
including length 
of stay and the 
need for 
pharmacological 
intervention, is 
decreased by 
increased 
promotion of 
Healthcare 
professionals should 
continue to 
encourage parental 
presence in 
providing care for 
the neonates 
suffering 
Barriers that impact the 
availability of the parents 
to stay involved with the 
neonates could be present 
in this type of situation, 
including a transportation 
deficit, additional child 
care duties, receiving 
opioid management 
treatment off-site, and 
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outcomes and 
symptoms. 
Research Question: 
Does increased parental 
presence in neonates 
experiencing 
withdrawal symptoms 
improve outcomes, 
including length of stay, 
the need for 
pharmacological 
interventions, and 
Finnegan scores?  
Sample size: 86 
mother-infant 
dyads  
rooming-in and 
parental 
involvement. 
withdrawal 
symptoms.   
guilty feelings while 
watching their infant 
experience withdrawal 
symptoms. Also, if the 
neonate requires care in 
the NICU, it is more 
difficult to promote 
parental presence. The 
information regarding 
which parent was present 
was not obtained in this 
study. 
8. Hünseler, C., Brückle, 
M., Roth, B., & Kribs, A. 
(2013). Neonatal opiate 
withdrawal and rooming-
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experience. Klinische 
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org.ezproxy.uakron.edu:24
43/10.1055/s-0033-
1347190 
Purpose Statement: The 
purpose was to assess 
the impact of rooming-
in with respect to the 
need for 
pharmacological 
treatment and length of 
stay for infants showing 
signs of NAS. 
Research Question: 
Does rooming-in make 
a difference in neonates 
experiencing NAS, 
related to length of stay 
and the need for 
pharmacological 
treatment?  
Setting: 
Children’s 
Hospital of the 
University of 
Cologne in 
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Sampling 
method: All 
patient charts 
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Sample size: 77 
infants 
Design: 
Retrospective 
comparison 
cohort study 
Level of 
Evidence: IV 
The number of 
days 
pharmacological 
treatment needed 
to be 
implemented and 
the length of stay 
decreased for 
infants who were 
part of a 
rooming-in 
program.   
“Rooming-in in 
NAS should be 
encouraged to 
shorten duration of 
therapy and length 
of hospital stay and 
thereby reduce 
costs. No major 
problems arose in 
the care of the 
infants with NAS 
when parents stayed 
with their infants 
but close monitoring 
of the newborn and 
strict instruction of 
parents are 
required.” 
(Hunseler, Bruckle, 
Roth, & Kribs, 
2013, p. 247) 
A retrospective study 
such as this lacks 
randomization so bias 
could have affected the 
results. Information 
regarding determination 
of the methadone dosing 
of the mothers at the time 
of delivery was not 
available and could have 
changed the severity of 
NAS symptoms in the 
infants.  
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9. Isemann, B., Meinzen-
Derr, J., & Akinbi, H. 
(2011). Maternal and 
neonatal factors impacting 
response to methadone 
therapy in infants treated 
for neonatal abstinence 
syndrome. Journal of 
Perinatology, 31(1), 25–
29. https://doi-
org.ezproxy.uakron.edu:24
43/10.1038/jp.2010.66 
Purpose Statement: The 
goal was to determine if 
there were maternal and 
neonatal factors that 
altered the need for 
methadone treatment in 
NAS neonate. 
Research Question: Is 
methadone maintenance 
therapy in infants 
correlated to 
nonpharmacological 
treatment such as 
breastfeeding?  
Setting: 
University 
Hospital in 
Cincinnati, OH 
Sampling 
method: All 
patient charts 
that met criteria 
Sample size: 128 
infants 
Design: 
Retrospective 
comparison 
cohort study 
Level of 
Evidence: IV 
Breastfeeding 
was associated 
with a shorter 
duration of 
methadone 
treatment 
compared with 
formula-fed 
infants. Ingestion 
of breastmilk 
decreased the 
hospital length 
of stay.  
Ingestion of 
breastmilk is linked 
to favorable 
outcomes in the 
NAS-affected 
neonates requiring 
methadone, so 
nurses and lactation 
consultants should 
work diligently with 
this high-risk 
population to 
promote 
breastfeeding.   
Incomplete data from the 
collection of medical 
records could alter the 
results of the study. 
Finnegan scoring is a 
subjective assessment 
subject to bias. Also, this 
was a retrospective study.  
10. Liu, A., Juarez, J., 
Nair, A., & Nanan, R. 
(2015). Feeding modalities 
and the onset of the 
neonatal abstinence 
syndrome. Frontiers in 
Pediatrics, 3(14), 1-4. 
https://doi-
org.ezproxy.uakron.edu:24
43/10.3389/fped.2015.000
14 
Purpose statement: The 
purpose of this study 
was to identify the 
correlation between 
different ways of 
feeding infants with 
NAS and the onset of 
withdrawal symptoms 
and need for 
pharmacological 
treatment. 
Research question: 
Does breastfeeding 
infants with NAS delay 
the onset of NAS 
symptoms and NAS 
treatment through 
pharmacological 
measures?  
Setting: two 
Western Sydney 
birthing units 
Sampling 
method: All 
patient charts 
that met criteria 
Sample size: 194 
methadone-
maintained 
mother/infant 
dyads 
Design: 
Retrospective 
comparison 
cohort study 
Level of 
Evidence: IV 
The need for 
NAS 
pharmacological 
treatment was 
reduced through 
breastfeeding 
implementation 
and was also 
associated with a 
delayed onset in 
NAS symptoms.  
Encouraging 
breastfeeding unless 
contraindicated 
related to medical 
issues is important 
to consider when 
communicating with 
methadone-
maintained women.  
There was a small sample 
size of mothers who only 
fed with expressed breast 
milk in this study due to 
the difficulty of this 
feeding method. Maternal 
self-reporting of drug use 
during pregnancy could 
be biased and could limit 
findings of the study.  
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11. McKnight, S., Coo, H., 
Davies, G., Holmes, B., 
Newman, A., Newton, L., 
& Dow, K. (2016). 
Rooming-in for infants at 
risk of neonatal abstinence 
syndrome. American 
Journal of Perinatology, 
33(5), 495–501. 
https://doi.org/10.1055/s-
0035-1566295  
Purpose Statement: This 
study analyzed if a 
rooming-in program 
had any effects on 
pharmacological 
treatment and 
hospitalization length of 
infants suffering from 
NAS.  
Research Question: 
Does rooming-in along 
with breastfeeding 
affect the length of stay 
of infants affected with 
neonatal abstinence 
syndrome, as well as 
decreasing the need for 
pharmacological 
treatment?  
Setting: 
Kingston 
General Hospital 
in Canada 
 
Sampling 
method: All 
patient charts 
that met criteria 
Sample size: 44 
Design: 
Retrospective 
comparison 
cohort study 
Level of 
Evidence: IV 
Neonates who 
participated in 
rooming-in with 
their mothers 
required less 
pharmacological 
treatment and 
had shorter 
lengths of stay in 
the hospital.  
Nurses should 
promote rooming-in 
and provide 
education about the 
benefits of rooming-
in and the reduced 
need for 
pharmacological 
treatment.  
There was no theoretical 
framework involved in 
this study. The sample 
size was insufficient, and 
the study was 
retrospective as 
evidenced by chart 
reviews from the past. A 
very small sample size 
related to rooming-in was 
noted so any accurate 
conclusions were able to 
be drawn. The mothers 
self-reported on their 
drug use, which is not 
reliable.  
12. McQueen, K. A., 
Murphy-Oikonen, J., 
Gerlach, K., & 
Montelpare, W. (2011). 
The impact of infant 
feeding method on 
neonatal abstinence scores 
of methadone-exposed 
infants. Advances in 
Neonatal Care, 11(4), 
282-290. 
http://doi.org/10.1097/AN
C.0b013e318225a30c  
 
Purpose Statement: The 
purpose of this study 
was to examine the 
effects of breastfeeding 
on the withdrawal 
symptoms of infants of 
mothers on methadone 
therapy.  
Research Question: Do 
infants exposed to 
opioids in utero who are 
breastfed by mothers on 
methadone, have 
decreased symptoms of 
NAS when compared 
Setting: Tertiary 
care center in 
Northwestern 
Ontario  
Sampling 
method: All 
patient charts 
that met criteria 
Sample size: 28 
Design: 
Retrospective 
comparison 
cohort study 
Level of 
Evidence: IV 
Breastfed infants 
had overall 
lower NAS 
scores compared 
to formula-fed 
infants. This 
suggests that 
there is an 
increased need 
for 
pharmacological 
treatment in the 
absence of 
breastfeeding.  
Nurses should 
provide 
encouragement to 
mothers on 
methadone 
maintenance 
treatment programs 
to promote 
breastfeeding, 
which is shown to 
decrease NAS 
symptoms in this 
type of situation. 
Additional information is 
needed to accurately 
explore this issue. 
“[G]roup allocation was 
self-selected according to 
the type of infant feeding, 
limiting the ability to 
control for potentially 
confounding variables” 
(McQueen et al., 2011, p. 
289).  
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with non-breastfed 
infants? 
13. Newman, A., Davies, 
G. A., Dow, K., Holmes, 
B., Macdonald, J., 
McKnight, S., & Newton, 
L. (2015). Rooming-in 
care for infants of opioid-
dependent mothers: 
Implementation and 
evaluation at a tertiary 
care hospital. Canadian 
Family Physician, 61(12), 
e555–e561. Retrieved 
from 
http://ezproxy.uakron.edu:
2048/login?url=http://sear
ch.ebscohost.com/login.as
px?direct=true&db=mnh&
AN=27035006&site=ehos
t-live 
Purpose Statement: A 
rooming-in program 
was implemented to see 
if increased contact 
between opioid-
dependent women and 
their infants had an 
impact on NAS scores, 
the need for 
pharmacological 
treatment, and length of 
hospital stay. 
Research Question: 
Does rooming-in 
decrease the number of 
infants experiencing 
severe NAS symptoms, 
the need for 
pharmacological 
interventions, and 
length of hospital stay? 
Setting: 
Kingston 
General Hospital 
in Ontario, Level 
3 NICU 
Sampling 
method: All 
patients of 
opioid dependent 
women at KGH 
antenatal clinic   
Sample size: 21 
mother-infant 
dyads 
Design: 
Retrospective 
comparison 
cohort study 
Level of 
Evidence: IV 
A drastic 
decrease in 
pharmacotherapy 
was observed, as 
the rate dropped 
from 83.3% to 
14.3% due to 
rooming-in 
efforts. Also, the 
length of stay 
dropped in this 
scenario.  
Through 
implementation of a 
program such as this 
study described, 
length of stay and 
the need for 
pharmacotherapy 
can be decreased, as 
well as an increase 
in maternal 
satisfaction. 
NAS scoring tools are 
subjective as the nurse 
who is implementing 
them uses their own 
judgment. A small 
sample size could have 
impacted the results of 
this study. 
14. O’Connor, A. B., 
Collett, A., Alto, W. A., & 
O’Brien, L. M. (2013). 
Breastfeeding rates and 
the relationship between 
breastfeeding and neonatal 
abstinence syndrome in 
women maintained on 
buprenorphine during 
pregnancy. Journal of 
Midwifery & Women’s 
Health, 58(4), 383–388. 
Purpose Statement: To 
quantify breastfeeding 
rates of pregnant 
women dependent on 
opioids who are on 
buprenorphine and the 
effects of breastfeeding 
on pharmacological 
standard of care.  
Research Question: 
Does breastfeeding with 
Setting: Maine 
General Medical 
Center 
Sampling 
method: All 
patient charts 
that met criteria 
Sample size: 85 
maternal-infant 
pairs 
Design: 
Retrospective 
cohort study 
Level of 
Evidence: IV 
Breastfeeding 
resulted in 
decreased NAS 
scores, and 
infants were less 
likely to receive 
pharmacological 
measures.  
Promoting 
breastfeeding 
among mothers with 
infants showing 
signs of NAS is 
important because 
rates have 
historically been 
lower when the 
mothers are on 
methadone. 
This was a retrospective 
chart review. It is 
difficult to determine the 
effectiveness of 
breastfeeding because 
there were other factors 
occurring simultaneously, 
such as swaddling and 
skin-to-skin contact. 
Information related to 
why or why not mothers 
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https://doi-
org.ezproxy.uakron.edu:24
43/10.1111/jmwh.12009  
women on 
buprenorphine during 
pregnancy decrease the 
duration, severity, and 
frequency of 
pharmacological 
treatment of NAS?  
breastfed was 
unavailable.  
15. Pritham, U. A., Paul, J. 
A., & Hayes, M. J. (2012). 
Opioid dependency in 
pregnancy and length of 
stay for neonatal 
abstinence syndrome. 
Journal of Obstetric, 
Gynecologic & Neonatal 
Nursing, 41(2), 180–190. 
https://doi-
org.ezproxy.uakron.edu:24
43/10.1111/j.1552-
6909.2011.01330.x 
Purpose Statement: This 
study aimed to examine 
the effects of 
breastfeeding mothers 
on neonatal outcomes 
and length of stay.  
Research Question: 
Does implementing 
breastfeeding with 
infants of mothers who 
had opioid replacement 
therapy (methadone vs. 
buprenorphine) during 
pregnancy decrease 
average length of stay 
and NAS symptoms? 
Setting: Eastern 
Maine Medical 
Center’s Labor 
and Delivery 
Unit and NICU 
Sampling 
method: All 
patient charts 
that met criteria 
Sample size: 152  
Design: 
Retrospective 
comparison 
cohort study 
Level of 
Evidence: IV 
Breastfeeding 
positively 
impacted 
(decreased) the 
length of stay in 
neonates 
affected with 
NAS, as well as 
decreased the 
rate of infant 
pharmacological 
treatment for 
withdrawal.  
Because NAS may 
increase the need 
for hospitalization 
and ultimately 
prevent early 
bonding, 
breastfeeding can 
promote 
maternal/infant 
bonding and 
attachment, 
decrease the need 
for NAS 
pharmacological 
treatment, and 
decrease 
hospitalization time.  
This study was 
performed by examining 
medical records; thus, 
prior documentation may 
not have been a 
completely accurate 
representation of care. 
Also, maternal drug use 
was self-reported by the 
women, which could lead 
to decreased levels 
reported, leading to 
unreliable information. 
16. Saiki, T., Lee, S., 
Hannam, S., & 
Greenough, A. (2010). 
Neonatal abstinence 
syndrome--postnatal ward 
versus neonatal unit 
management. European 
Journal Of Pediatrics, 
169(1), 95–98. 
https://doi.org/10.1007/s00
431-009-0994-0  
Purpose Statement: The 
goal was to test the idea 
that caring for infants 
with NAS in the same 
room as their mothers 
would decrease the 
extent of treatment 
needed and length of 
stay.  
Research Question: 
Does treating infants 
Setting: King’s 
College Hospital  
Sampling 
method: All 
patient charts 
that met criteria 
Sample size: 60 
infants 
Design: 
Retrospective 
comparison 
cohort study 
Level of 
Evidence: IV 
“These results 
suggest caring 
for infants with 
NAS on the 
postnatal ward 
rather than the 
neonatal unit 
reduces the need 
for treatment and 
duration of 
hospital stay” 
Rooming-in 
programs should be 
implemented when 
caring for mothers 
who abused drugs 
during pregnancy to 
shorten hospital 
stays, instead of 
admitting the infants 
to the NICU. 
The two different groups 
in the study were 
managed by different 
teams, which could have 
resulted in different 
methods of care. Also, 
this study was not 
randomized, and it was a 
retrospective study.  
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with NAS on the 
postnatal ward with 
mothers, versus the 
NICU, decrease 
treatment need and 
length, as well as length 
of stay? 
(Saiki et al., 
2010, p. 95). 
17. Schiff, D. M., 
Wachman, E. M., Philipp, 
B., Joseph, K., Shrestha, 
H., Taveras, E. M., & 
Parker, M. G. K. (2018). 
Examination of hospital, 
maternal, and infant 
characteristics associated 
with breastfeeding 
initiation and continuation 
among opioid-exposed 
mother-infant dyads. 
Breastfeeding Medicine, 
13(4), 266–274. 
https://doi-
org.ezproxy.uakron.edu:24
43/10.1089/bfm.2017.017
2  
Purpose Statement: To 
determine the number 
of mothers who met 
criteria for 
breastfeeding per 
hospital 
recommendations and 
to examine 
breastfeeding initiation 
rates associated with 
maternal and infant 
characteristics and 
hospital initiatives.  
Research Question: 
Among infants exposed 
with opioids in utero, do 
hospital, maternal, and 
infant characteristics 
affect breastfeeding 
rates and duration? 
Setting: Boston 
Medical Center 
Sampling 
method: All 
patient charts 
that met criteria 
Sample size: 564 
Design: 
Retrospective 
comparison 
cohort study 
Level of 
evidence: IV 
There was a 
nearly three 
times greater 
odds of 
breastfeeding 
after initiation of 
NAS quality 
improvement 
measures and 
relaxation of 
guideline 
restrictions 
regarding 
breastfeeding 
with opioid-
abusing mothers.  
Breastfeeding 
should be initiated 
and continued after 
hospital care. 
Support groups and 
proper education to 
help continuation of 
breastfeeding past 
hospital stays can 
help prevent a 
decreased 
percentage of 
breastfeeding 
mothers.  
This was a retrospective 
study. Breastfeeding 
success may be hindered 
by a common 
characteristic of NAS: a 
poor suck and latch 
related to breastfeeding. 
Tracking breastfeeding 
initiatives and support 
prior to care was not 
possible in this study.  
18. Short, V. L., Gannon, 
M., & Abatemarco, D. J. 
(2016). The association 
between breastfeeding and 
length of hospital stay 
among infants diagnosed 
with neonatal abstinence 
syndrome: A population-
Purpose Statement: This 
study was conducted, 
“to examine the 
association between 
breastfeeding and 
length of hospital stay 
among infants 
diagnosed with NAS” 
Setting: 
Pennsylvania 
Sampling 
method: All 
patient charts 
that met criteria 
Design: 
Retrospective 
comparison 
cohort study 
Level of 
Evidence: IV 
Breastfed infants 
are found to 
have shortened 
hospitalizations 
and decreased 
incidence of 
adverse effects 
compared with 
Supporting mothers 
in breastfeeding and 
communicating the 
beneficial outcomes 
can be beneficial for 
infants with NAS 
symptoms.  
There was not enough 
information regarding 
exposure to 
pharmacological 
treatment during 
pregnancy and 
postpartum. 
Classification and 
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based study of in-hospital 
births. Breastfeeding 
Medicine, 11(7), 343–349. 
https://doi-
org.ezproxy.uakron.edu:24
43/10.1089/bfm.2016.008
4 
(Short, Gannon, & 
Abatemarco, 2016, p. 
343) 
Research Question: Is 
there a significant 
relationship between 
breastfeeding and 
hospital length of stay 
for infants with NAS? 
Sample size: 
3,725 NAS cases  
non-breastfed 
infants.  
assessment of NAS 
varies among healthcare 
providers. The drugs used 
in opioid dependence 
treatment were not 
identified, which could 
impact the results.  
19. Welle-Strand, G. K., 
Skurtveit, S., Jansson, L. 
M., Bakstad, B., Bjarkø, 
L., & Ravndal, E. (2013). 
Breastfeeding reduces the 
need for withdrawal 
treatment in opioid-
exposed infants. Acta 
Paediatrica, 102(11), 
1060–1066. https://doi-
org.ezproxy.uakron.edu:24
43/10.1111/apa.12378  
Purpose Statement: To 
assess whether 
breastfeeding rates and 
durations have an 
impact on the symptoms 
of NAS and the need for 
pharmacological 
treatment. 
Research Question: 
How are characteristics 
of neonate outcomes 
different from those 
who breastfed versus 
those who did not?   
Setting: 
Norwegian 
Medical Birth 
Registry and the 
Norwegian 
Center for 
Addiction 
Research 
Sampling 
method: 
Recruitment 
from OMT 
centers 
Sample size: 124 
Design: 
Comparison 
study of a 
cohort, 2 
parts were 
retrospective 
Level of 
Evidence: IV 
Breastfeeding is 
a positive 
intervention for 
infants exposed 
to buprenorphine 
or methadone in 
utero. Lower 
incidences of 
NAS are also 
associated with 
breastfeeding. 
As nurses, we 
should encourage 
people in this 
population to 
breastfeed, as well 
as provide 
information and 
support for this 
vulnerable group of 
mothers and infants 
on how to 
breastfeed.  
There was no theoretical 
framework in this study. 
The study was not as 
accurate due to being a 
retrospective study. The 
children were born at 18 
different hospitals, so 
NAS scores could differ 
as they were done by 
different nurses. The 
extent of breastfeeding 
was not measured in the 
questionnaire. The 
buprenorphine sample 
size was relatively small 
to draw any significant 
conclusions.  
20. Yonke, N., Maston, R., 
Weitzen, S., & Leeman, L. 
(2018). Breastfeeding 
intention compared with 
breastfeeding postpartum 
among women receiving 
medication-assisted 
treatment. Journal Of 
Human Lactation, 1(1), 1-
Purpose Statement: The 
study attempted to 
compare the number of 
prenatal women who 
said they wanted to 
breastfeed to the 
number who were 
actually breastfeeding at 
discharge, as well as 
Setting: 
University of 
New Mexico 
Hospital 
Sampling 
method: All 
patient charts 
that met criteria 
Design: 
Longitudinal 
retrospective 
cohort study  
Level of 
evidence: IV 
A decreased 
need for 
pharmacological 
treatment was 
found to be 
associated with 
breastfeeding 
compared to 
formula-feeding 
Promotion of 
breastfeeding in 
women who have 
neonates who are 
experiencing NAS 
symptoms is 
important. 
Education regarding 
breastfeeding can be 
Due to being a 
retrospective study, there 
was a lack of power and 
qualitative data. No 
information was present 
on why breastfeeding 
was initiated or stopped.  
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9.. https://doi-
org.ezproxy.uakron.edu:24
43/10.1177/089033441876
9637 
analyzing the impacts of 
breastfeeding on NAS 
symptoms in the 
affected neonates.  
Research Question: 
Does prenatal education 
on breastfeeding with 
women who are 
dependent on opioids 
during pregnancy 
increase the likelihood 
of continuing 
breastfeeding after birth 
and decrease the 
symptoms of NAS in 
newborns?  
Sample size: 228 when analyzing 
withdrawal 
symptoms. 
an asset to this type 
of situation.  
 
 
